New blood thinner could be safer for sepsis patients on dialysis
Disease control
Not yet recruiting
This study tests whether a newer blood thinner, nafamostat mesylate, works as well as the standard citrate during continuous kidney dialysis in people with sepsis-related kidney injury. About 1,162 adults will be randomly assigned to receive one of the two drugs. The main goal is…
Phase: PHASE4 • Sponsor: Jianfeng Xie • Aim: Disease control
Last updated May 15, 2026 11:57 UTC